Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix® in Acute Coronary Syndrome Patients Undergoing Angioplasty
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix® in Acute Coronary Syndrome Patients Undergoing Angioplasty
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix® in Acute Coronary Syndrome Patients Undergoing Angioplasty
Submitted by
admin
on August 30, 2009 - 9:33am
Source:
Business Wire
News Tags:
Plavix
Bristol-Myers Squibb
Sanofi
Headline:
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix® in Acute Coronary Syndrome Patients Undergoing Angioplasty
Do Not Allow Advertisers to Use My Personal information
